SQZ Biotechnologies Co
SQZDelisted Jul 19, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001604477
SQZ Biotechnologies Co was delisted on Jul 19, 2023; its insiders filed their last Form 4 on Jun 15, 2023; 31 institutions reported holding it in 13F filings for Q2 2023, worth $2.96M in total; Maverick Capital was the only superinvestor holding it.
Q3 2022 vs. Q2 2022
How the institutions holding SQZ Biotechnologies Co changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 53 | 48 | −5 |
| Shares | 14.8M | 14.7M | −142.5K (−1.0%) |
| Value | $47.1M | $33.5M | −$13.7M (−29.0%) |
New holders (4)
Institutions that held SQZ Biotechnologies Co at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Balyasny Asset Management LLC | 12,404 | $28.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 10,561 | $24.0K | 0.00% |
| BNP Paribas Arbitrage, SA | 4,247 | $9.68K | 0.00% |
| TD Waterhouse Canada Inc. | 1,000 | $3.15K | 0.00% |
Sold out (9)
Institutions that held SQZ Biotechnologies Co at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Millennium Management LLC | 92,286 | $293.0K |
| Susquehanna International Group, LLP | 13,549 | $43.0K |
| PDT Partners, LLC | 11,740 | $37.0K |
| Occudo Quantitative Strategies LP | 11,307 | $36.0K |
| Russell Investments Group, Ltd. | 8,192 | $26.0K |
| FMR LLC | 209 | $1.00K |
| New York State Common Retirement Fund | 194 | $1.00K |
| Advisor Group Holdings, Inc. | 256 | $1.00K |
| Credit Suisse AG | 12 | $0 |